Breaking News, Financial News

Financial Report: BASi

Restructuring charges impact results

BASi
 
3Q Revenues: $7.2 million (-15%)

3Q Loss: $704,000 (earnings were $418 million 3Q11)

YTD Revenues: $21.7 million (-13%)

YTD Loss: $4.1 million (earnings were $1.2 million YTD11)

Comments: Service revenue was $5.2 million in the quarter (-23%). Product revenue was $2.0 million (+14%). Restructuring charges were $623,000 in the quarter and $687,000 YTD.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters